Recent bulletins and guidelines from ACMG, ACOG, ISPD, and ASHG/ESHG recommend a discussion of NIPT with all patients (both high risk and average risk) at their first prenatal visit. Are you having the conversation? We have compiled key resources for you to use when expanding your genetic testing offering to all women.
More than 68,613 patients < 35 years of age at gestation have been evaluated in 8 studies to provide further clarity around the clinical benefits of prenatal testing.
The American Congress of Obstetrics & Gynecologists, among other societies, now acknowledges the use of NIPT for all singleton pregnancies, regardless of age or risk.
31 commercial health plans, comprised of roughly 92 million covered lives, have revised their medical policy to include NIPT for all singleton pregnancies.
Natera provides a variety of complementary tools to patients and physicians to assist when further information is needed at any stage of the NIPT testing process, from pre- and post-test genetic counseling, test cost estimator, and more.